Facts, not Fear: Safety of Hydroxychloroquine
- 10 May 2020
- journal article
- letter
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 360 (2), 199-200
- https://doi.org/10.1016/j.amjms.2020.05.003
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic reviewJournal of the American Academy of Dermatology, 2020
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm SocietyCanadian Journal of Cardiology, 2020
- Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?The Journal of Rheumatology, 2018
- Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus2018
- Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH‐Deficient PatientsArthritis Care & Research, 2018
- Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to HydroxychloroquineCase Reports in Cardiology, 2016
- Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine RetinopathyOphthalmology, 2011